PT  - JOURNAL ARTICLE
AU  - Wolters, E.Ch.
AU  - Jansen, E.N.H.
AU  - Tuynman-Qua, H. G.
AU  - Bergmans, P. L.M.
TI  - Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
AID  - 10.1212/WNL.47.4.1085
DP  - 1996 Oct 01
TA  - Neurology
PG  - 1085--1087
VI  - 47
IP  - 4
4099  - http://n.neurology.org/content/47/4/1085.short
4100  - http://n.neurology.org/content/47/4/1085.full
SO  - Neurology1996 Oct 01; 47
AB  - We studied the effect of olanzapine (1 to 15 mg/d) in 15 nondemented parkinsonian patients with drug-induced psychosis. Psychotic symptoms decreased significantly during treatment, and there was no worsening of extrapyramidal symptoms. These results suggest that olanzapine is a well-tolerated and effective treatment for drug-induced psychosis in nondemented patients with Parkinson's disease. NEUROLOGY 1996;47: 1085-1087